Both in Biotechnology
Entera Bio vs 4D Molecular Therapeutics
Over the past year ENTX returned +13.5% and FDMT returned +5.1%; their daily moves had a correlation of 0.21.
ENTX +13.5% FDMT +5.1%Growth of $1, one year, split-adjusted
| Metric | ENTX | FDMT |
|---|---|---|
| Price | $3.20 | $11.90 |
| Market cap | $556.6M | $657.4M |
| Today | +2.56% | −6.89% |
| 1 month | +10.7% | −14.0% |
| 6 months | +190.9% | +30.9% |
| Year to date | +64.9% | +58.7% |
| 1 year | +17.2% | +4.3% |
| Revenue growth (YoY) | — | +25106.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −1929.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.1× |
| Net cash | $11.0M | $341.7M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 75.3% |
| Short % of float | 3.5% | 21.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).